Breakthrough aims to shorten the time women wait for effective treatment from an average of five years to just five months| Wyss InstituteWyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Namita Sarraf loves to find herself at intersections, whether it’s pursuing a Ph.D. at the nexus of bioengineering and computer science or hosting a...| Wyss Institute
Organ Chips are microfluidic devices lined with living human cells for drug development, disease modeling, and personalized medicine. Launched in 2014, Wyss startup Emulate, Inc., is leveraging the Wyss Institute’s Organ Chip technology to mimic human organs in vitro, enabling faster, better, and cheaper drug development and insights into human health.| Wyss Institute
Over 15 million Americans are at risk of anaphylaxis, a severe allergic reaction triggered by exposure to certain foods, materials, medications, and insect bites. Every three minutes, a food reaction sends someone to the emergency room. In most individuals, anaphylactic shock can be prevented by administering the counteracting drug epinephrine, as soon as an attack...| Wyss Institute
StataDX licensed the eRapid portable electrochemical sensing technology to develop diagnostics for neurological, cardiovascular, and renal diseases with a first focus on building a point-of-care platform for difficult-to-detect neurological disorders.| Wyss Institute
Humans of the Wyss Simon D’Oelsnitz on PFASense| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Simon D’Oelsnitz always keeps the potential applications of his science at the top of mind. When he studied pharmacology, he thought about the customers...| Wyss Institute
Elliot is Chairman of the Roberta and Stephen R. Weiner Department of Surgery and Surgeon-in-Chief at Beth Israel Deaconess Medical Center (BIDMC). Dr. Chaikof has promoted alliances of clinicians, engineers, chemists, and biologists and in the process developed biologically-inspired materials, devices, and pharmacotherapeutics based upon the principles of molecular engineering and nanofabrication technologies. These endeavors...| Wyss Institute
Every year the Wyss Institute names a class of Validation Projects whose teams receive dedicated funding, business development support, and other resources to advance their promising technologies towards commercialization. They also collaborate with key opinion leaders, investors, and potential customers to de-risk their innovations and speed their progress to the market. This year, we’re thrilled...| Wyss Institute
Browse photos from our community, inspired by science, technology, and Nature| Wyss InstituteWyss Institute
New stem cell differentiation method is first to induce meiosis, a critical step in egg and sperm cell development, with potential for drug development and future fertility treatments| Wyss InstituteWyss Institute
Throughout recent years, the Wyss’ Validation Project mechanism has proven to be a highly valuable instrument for selecting and kick-starting projects with early potential for positive impact on healthcare and the environment. Reaching deep into areas with major unmet needs across the diverse Grand Challenges laid out by the Institute, the newly selected projects are...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Anastasia Ershova loves fencing because every opponent is a new puzzle to solve, and both fencers are constantly engaged, making adjustments based on each...| Wyss Institute
AI-enabled drug discovery approach identified potentially game-changing treatment, which has been advanced from the lab bench to an FDA Orphan Drug Designation in record time| Wyss InstituteWyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. In 2018, Sanjid Shahriar started developing two new skills: powerlifting and computational biology. Each was started with an initial goal of complementing things he already possessed…| Wyss InstituteWyss Institute
Patient-matched Organ Chips mimicking the tumor microenvironment can effectively personalize chemotherapy selection in cancer patients| Wyss InstituteWyss Institute
Handheld electrochemical sensors have revolutionized at-home medical testing for diabetics, but they have not yet been successfully applied to diagnosing other conditions. These sensors are based on the activity of an enzyme, and there are only a limited number of enzymes that can be used to detect biomarkers of human disease. An alternative, much more...| Wyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute for Biologically Inspired Engineering at Harvard University has been awarded funding from Wellcome Leap’s $50 million The Missed Vital Sign program, which seeks to transform how menstruation is understood and treated in healthcare. The Wyss will use its pioneering Organ Chip technology to create the first human...| Wyss Institute
By Alexandra Jirstrand (BOSTON) – The Wyss Institute at Harvard University, its Board of Directors, and Executive Leadership are pleased to announce that Natalie Artzi, Ph.D., has been appointed to a newly created position as Associate Institute Director of the Wyss Institute. In her new role, Artzi will work closely with the Wyss Founding Director...| Wyss Institute
The Humans of the Wyss (HOW) series features members of the Wyss community discussing their work, the influences that shape them as professionals, and their collaborations at the Wyss Institute and beyond. Sayo Eweje loves finding solutions, whether he’s looking at a Rubik’s Cube or a technical challenge in the lab. When faced with the problem...| Wyss Institute
By Lindsay Brownell (BOSTON) — Getting medicines into the cells they’re designed to treat is a perennial problem for the medicine and pharmaceutical industries, and patients often suffer from side effects and ineffective treatments as a result. Current drug delivery vehicles carry a host of risks and limits: lipid nanoparticles can cause immune reactions and...| Wyss Institute
By Don Ingber Credit: Wyss Institute at Harvard University On April 11, we at the Wyss Institute welcomed more than 550 researchers, industry leaders, physicians, and entrepreneurs to our Annual Retreat in which we shared the amazing progress our community has made in the development of new bioinspired diagnostics, devices, and therapeutics for both human...| Wyss Institute
Donald E. Ingber, M.D., Ph.D., is the Founding Director of the Wyss Institute for Biologically Inspired Engineering at Harvard University, Judah Folkman Professor of Vascular Biology at Harvard Medical School and the Vascular Biology Program at Boston Children’s Hospital, and Hansjörg Wyss Professor of Biologically Inspired Engineering at the Harvard John A. Paulson School of...| Wyss Institute
By Benjamin Boettner This video explains the basic principles of eRapid as an electrochemical sensing platform, and how it could be used for low-cost, multiplexed detection of a wide range of biomolecules for diagnostic applications. Credit: Wyss Institute at Harvard University (BOSTON) – In an article published in the prestigious Accounts in Chemical Research, Wyss...| Wyss Institute
Michael Levin, a Distinguished Professor in the Biology department at Tufts, holds the Vannevar Bush endowed Chair and serves as director of the Allen Discovery Center at Tufts and the Tufts Center for Regenerative and Developmental Biology. Recent honors include the Scientist of Vision award and the Distinguished Scholar Award. His group’s focus is on understanding...| Wyss Institute
Study suggests a pain relief drug that can quickly and reversibly induce a sleep-like state in cells and organs could facilitate organ transplantation and prevent irreversible tissue injury| Wyss Institute
Wyss Institute’s Biostasis team advances science right on schedule| Wyss Institute